Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry
Language English Country England, Great Britain Media print-electronic
Document type Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't
- Keywords
- EUROASPIRE, cardiovascular risk factors, guidelines, lifestyle, secondary prevention,
- MeSH
- Patient Compliance MeSH
- Risk Reduction Behavior * MeSH
- Diet adverse effects MeSH
- Risk Assessment MeSH
- Cardiovascular Agents therapeutic use MeSH
- Cardiovascular Diseases diagnosis epidemiology physiopathology prevention & control MeSH
- Smoking adverse effects epidemiology MeSH
- Middle Aged MeSH
- Humans MeSH
- Protective Factors MeSH
- Cross-Sectional Studies MeSH
- Health Care Surveys MeSH
- Registries MeSH
- Risk Factors MeSH
- Sedentary Behavior MeSH
- Secondary Prevention MeSH
- Aged MeSH
- Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use MeSH
- Treatment Outcome MeSH
- Health Status MeSH
- Healthy Lifestyle * MeSH
- Life Style * MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Multicenter Study MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- Europe epidemiology MeSH
- Names of Substances
- Cardiovascular Agents MeSH
- Hydroxymethylglutaryl-CoA Reductase Inhibitors MeSH
AIMS: The aim of this study was to determine whether the Joint European Societies guidelines on secondary cardiovascular prevention are followed in everyday practice. DESIGN: A cross-sectional ESC-EORP survey (EUROASPIRE V) at 131 centres in 81 regions in 27 countries. METHODS: Patients (<80 years old) with verified coronary artery events or interventions were interviewed and examined ≥6 months later. RESULTS: A total of 8261 patients (females 26%) were interviewed. Nineteen per cent smoked and 55% of them were persistent smokers, 38% were obese (body mass index ≥30 kg/m2), 59% were centrally obese (waist circumference: men ≥102 cm; women ≥88 cm) while 66% were physically active <30 min 5 times/week. Forty-two per cent had a blood pressure ≥140/90 mmHg (≥140/85 if diabetic), 71% had low-density lipoprotein cholesterol ≥1.8 mmol/L (≥70 mg/dL) and 29% reported having diabetes. Cardioprotective medication was: anti-platelets 93%, beta-blockers 81%, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers 75% and statins 80%. CONCLUSION: A large majority of coronary patients have unhealthy lifestyles in terms of smoking, diet and sedentary behaviour, which adversely impacts major cardiovascular risk factors. A majority did not achieve their blood pressure, low-density lipoprotein cholesterol and glucose targets. Cardiovascular prevention requires modern preventive cardiology programmes delivered by interdisciplinary teams of healthcare professionals addressing all aspects of lifestyle and risk factor management, in order to reduce the risk of recurrent cardiovascular events.
1st Department of Cardiology Medical School National and Kapodistrian University of Athens Greece
ANMCO Research Centre Florence Italy
Assiut University Heart Hospital Cardiovascular Medicine Department Egypt
AZ Maria Middelares Ghent Belgium
Cardiac Rehabilitation Unit Cardiology Department Hospital Universitario La Paz Madrid Spain
Centre of Cardiology and Angiology Vilnius University Hospital Santaros Klinikos Lithuania
Clinic for Internal Disease Intermedic Cardiology Department Hypertension Centre Nis Serbia
Clinic of Cardiac and Vascular diseases Medical Faculty Vilnius University Lithuania
Clinical Trial Centre University Hospital Würzburg Germany
Comprehensive Heart Failure Centre University and University Hospital Würzburg Germany
Department of Cardiology Hacettepe University Ankara Turkey
Department of Internal Medicine and Paediatrics Ghent University Belgium
Department of Medicine 1 University Hospital Würzburg Germany
Department of Medicine Internal Medicine Lausanne University Hospital Switzerland
Department of Medicine Solna Karolinska Institutet Stockholm Sweden
Department of Public Health and Primary Care Ghent University Belgium
Erasmus MC Rotterdam The Netherlands
European Society of Cardiology Sophia Antipolis France
Hospital Santa Cruz Centro Hospitalar de Lisboa Ocidental Lisbon Portugal
Hospital Santa Marta Centro Hospitalar de Lisboa Central Lisbon Portugal
Institute of Cardiology and Regenerative Medicine University of Latvia Riga Latvia
Institute of Clinical Epidemiology and Biometry University of Würzburg Germany
Julius Centre for Health Sciences and Primary Care University Medical Centre Utrecht The Netherlands
Kyrgyz State Medical Academy Bishkek Kyrgyzstan
Medical Faculty University of Ljubljana Slovenia
Medical Faculty University of Sarajevo Bosnia and Herzegovina
National Heart and Lung Institute Imperial College London UK
National Heart Hospital Dept Cardiology Sofia Bulgaria
National Research Centre for Preventive Medicine Directorate Moscow Russia
National University of Ireland Galway Ireland *Listed in Supplemental Appendix
Pauls Stradins Clinical University Hospita University of Latvia Riga Latvia
Supyk National Medical Academy of Postgraduate Education Kiev Ukraine
University Hospital Centre Zagreb School of Medicine University of Zagreb Croatia
University of Zagreb School of Medicine and University Hospital Centre Zagreb Croatia
References provided by Crossref.org
Kreislaufstillstand unter besonderen Umständen: Leitlinien des European Resuscitation Council 2021
